ARCHIVES

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

ACS Updates Guidelines On Colorectal Screening.

February 2, 2001

In Brief: Survey Expected To Stimulate Surge Of Interest In Finding Etiological Factors In U .S. County-By-County Variations

April 19, 1974

Nutrition Program Starts To Zero In On Mass Of Data, Plan Contract And Grant Project Areas

August 29, 1975

Colorectal Cancer Incidence Rising Worldwide

June 12, 2009

ACS Approves New Workplaces Intervention Cancer Control Program

April 17, 1992

In Brief: Hazleton Acquires Prime Labs, Primate Importer; Cullen UCLA Deputy Director

July 30, 1976